This was an independent session organised by MGP without financial support or involvement from the pharmaceutical industry.
This site is intended for UK healthcare professionals
Related video
Dr Kevin Fernando Q&A on type 2 diabetes
Dr Kevin Fernando answers questions on the impact of type 2 diabetes on patients’ daily lives, differences between NICE and SIGN guidance, and key take-home messages for primary care
Latest video
Related articles
PHE/DH/DWP guidelinePHE COVID-19 vaccination guidance
A concise summary of guidance for healthcare professionals about the COVID-19 vaccination programme
- News
NICE publishes prescribing strategy for secondary bacterial infection of eczema
The new NICE guideline sets out an antimicrobial prescribing strategy for secondary bacterial infection of eczema and covers infection of other common skin conditions
- Supplement
The re-usable Respimat® Soft Mist inhaler
This promotional supplement has been commissioned and funded by Boehringer Ingelheim Ltd and developed in partnership with Guidelines.
View prescribing information
PC-GB-103141 November 2020
More Videos
- Video
Dr Glenis Scadding Q&A on rhinitis
This session was supported by an educational grant from Mylan Ltd. Dr Glenis Scadding comments on the main presentations of rhinitis, its impact on patients’ daily lives, red flags for referral, and the main recommendations of the 2017 BSACI guideline
- Video
Guidelines Live 2018 overview with Dr Matthew Fay
Dr Matt Fay, Chair of Guidelines Live 2018, provides his thoughts on the programme from a primary care perspective, and summarises the meetings.
No comments yet